PRIP Component B: financial assistance for research and innovation
A programme by Department of Pharmaceuticals
Financial assistance for pharma and medtech research and innovation projects, for companies, LLPs and registered partnership firms.
At a glance
| Best for | Companies, LLPs and registered partnership firms in India, working on pharma or medtech research and innovation |
|---|---|
| Grant support | For selected startups. A place in the programme does not by itself guarantee a grant. |
About PRIP Component B: financial assistance for research and innovation
The Scheme for Promotion of Research and Innovation in Pharma MedTech (PRIP) is run by the Department of Pharmaceuticals. Its Component B gives financial assistance to eligible entities for research and innovation projects. The guidelines are dated 1 October 2025, and no open application window is listed.
What you get
- Financial assistance for an eligible project
- An optional benefit-share route, under which the beneficiary issues compulsorily convertible preference shares to the Central Government, equal in value to the assistance disbursed
Who can apply
- Companies, LLPs and registered partnership firms registered in India
- Early-stage projects also need a Startup certificate from the Inter-Ministerial Board of Certification, or a valid Udyam MSME registration
How to apply: The scheme runs through the PRIP portal. Confirm that a call is open there before you plan an application.
Where to apply
Other Department of Pharmaceuticals programmes
- Scheme for Strengthening of Medical Device Industry (SMDI)Grant-in-aid towards equipment and machinery for medical device makers, running from FY 2024-25 to FY 2026-27.
- Production Linked Incentive (PLI) Scheme for PharmaceuticalsProduction-linked incentive for manufacturing high-value pharmaceutical goods in India, with a tenure from FY 2020-21 to FY 2028-29.
- Production Linked Incentive (PLI) Scheme for critical key starting materials, drug intermediates and APIsProduction-linked incentive for domestic manufacture of key starting materials, drug intermediates and active pharmaceutical ingredients (APIs).
- Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical DevicesProduction-linked incentive for greenfield medical device manufacturing projects by Indian companies and LLPs.
- Pradhan Mantri Bhartiya Janaushadhi Kendra (PMBJK): opening a new kendraRun a Janaushadhi medicine kendra for a margin and an incentive, open to pharmacy degree holders and NGOs.